Journal Articles
Barozzi, Nadia, Peeters, GMEE Geeske and Tett, Susan E. (2015). Actions following adverse drug events – how do these influence uptake and utilisation of newer and/or similar medications. BMC Health Services Research, 15 (498) 498, 498. doi: 10.1186/s12913-015-1165-9
Tett, Susan E., Sketris, Ingrid, Cooke, Charmaine, Velhuyzen van Zanten, Sander and Barozzi, Nadia (2013). Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada. Pharmacoepidemiology and Drug Safety, 22 (7), 735-743. doi: 10.1002/pds.3442
Barozzi, Nadia, Sketris, Ingrid, Cooke, Charmaine and Tett, Susan (2009). Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2)inhibitors use in Australia and Nova Scotia (Canada). British Journal of Clinical Pharmacology, 68 (1), 106-115. doi: 10.1111/j.1365-2125.2009.03410.x
Barozzi, N. and Tett, S. E. (2009). Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing. Clinical Therapeutics, 31 (4), 849-861. doi: 10.1016/j.clinthera.2009.04.012
Barozzi, N. and Tett, S. E. (2009). Perceived barriers to paracetamol (acetaminophen)prescribing, especially following rofecoxib withdrawal from the market. Clinical Rheumatology, 28 (5), 509-519. doi: 10.1007/s10067-008-1077-8
Barozzi, Nardia and Tett, Susan E. (2008). Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia. BMC Health Services Research, 8 (Article Number: 196) 196, 196-1-196-9. doi: 10.1186/1472-6963-8-196
Abdel-Aal, Abu-Baker M., Batzloff, Michael R., Fujita, Yoshio, Barozzi, Nadia, Faria, Andres, Simerska, Pavla, Moyle, Peter M., Good, Michael F. and Toth, Istvan (2008). Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group A streptococcal vaccine candidates. Journal of Medicinal Chemistry, 51 (1), 167-172. doi: 10.1021/jm701091d
Barozzi, N. and Tett, S. E. (2007). Cox-2 inhibitor influence on non-steroidal antiinflammatory drug (NSAIDs) and paracetamol use in 6 countries. Pharmacoepidemiology And Drug Safety, 16 (s2), S80-S80. doi: 10.1002/pds.1461
Barozzi, N. and Tett, S. E. (2007). What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?. Pharmacoepidemiology and Drug Safety, 16 (11), 1184-1191. doi: 10.1002/pds.1451
Olive, Colleen, Ho, Mei‐Fong, Dyer, Joanne, Lincoln, Douglas, Barozzi, Nadia, Toth, Istvan and Good, Michael F. (2006). Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. Journal of Infectious Diseases, 193 (12), 1666-1676. doi: 10.1086/504266
Everett, Ruth S., Vanhook, Miriam K., Barozzi, Nadia, Toth, Istvan and Johnson, Larry G. (2006). Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide. Molecular Pharmacology, 69 (2), 492-500. doi: 10.1124/mol.105.017251
Conference Papers
Barozzi, N. and Tett, S.E. (2007). Perceived barriers to acetaminophen prescribing, especially following rofecoxib withdrawal from the market. 4th Canadian Therapeutics Congress, Halifax, Nova Scotia, Canada, 27-30 May 2007. Canada: Pulsus Group Inc.
Moyle, Peter Michael, Olive, Colleen, Karpati, Levente, Barozzi, Nadia, Ho, Mei-Fong, Dyer, Joanne, Sun, Hsien Kuo, Good, Michael and Toth, Istvan (2006). Synthesis and immunological evaluation of M protein targeted tetra-valent and tri-valent group A streptococcal vaccine candidates based on the lipid-core peptide system. 6th Australian Peptide Conference, Whitsunday Islands, Australia, 9-14 October, 2005. Netherlands: Springer. doi: 10.1007/s10989-006-9021-8
Barozzi, N. and Tett, S. E. (2006). Evaluating how guidelines for replacement therapy were implemented following withdrawal of rofecoxib. The National Institute of Clinical Studies Using Evidence: Using, Melbourne, 19-20 October 2006. Melbourne: National Institute of Clinical Studies.
Barozzi, N. and Tett, S. E. (2006). How did rofecoxib withdrawal influence overall non-steroidal anti-inflammatory drug (NSAIDs) and paracetamol prescribing in Australia?. Quality Use of Medicines: Balancing Beliefs, Benefits and Harms, Canberra / National Convention Centre, 7-9 June 2006. Canberra: National Prescribing Service Limited.
Barozzi, N. and Tett, S. E. (2006). Non-steroidal anti-inflammatory drug prescription in relation to the prescribing of gastroprotective drugs in Australia. 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Lisbon, Portugal, 24-27 August 2006. Chichester, West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/pds.1295
Barozzi, N. and Tett, S.E. (2005). Use of non-selective non-steroidal anti-inflammatory drugs (NSAID), COX-2 inhibitors (COX-2) and paracetamol. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.
Thesis
Nadia Barozzi (2008). Improving the use of prescription medicines : exploration of international comparisons of utilisation and other strategies to influence more rational use of specific medicines. PhD Thesis, School of Pharmacy, The University of Queensland.